Company Profile

Stronger Sell Today ADMP ranks #5435 as SELL CANDIDATE #5435 Weaker Sell

Adamis Pharmaceuticals Corporation stock forecast

ADMP stock forecast

Adamis Pharmaceuticals Corporation

11682 El Camino Real

San Diego, CA 92130


Industry: Drug Delivery

Sector: Healthcare


Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, engages in developing and commercializing products in the therapeutic areas of allergy and respiratory disease. Its specialty pharmaceutical product candidates include the Epinephrine Injection PFS syringe product for use in the emergency treatment of anaphylaxis; APC-1000 and APC-5000 for the treatment of asthma and chronic obstructive pulmonary disease; and APC-2000 for the treatment of bronchospasms. The company also has various biotechnology product candidates and technologies, including therapeutic vaccine and cancer product candidates that comprise TeloB-VAX (vaccine), APC-100, APC-200, and APC-300, which are under development for the treatment of prostate cancer. In addition, it operates a 503B drug outsourcing facility that provides prescription medications to patients, physician clinics, hospitals, and surgery centers in the United States. The company is headquartered in San Diego, California.

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank